Hester Biosciences
Hester Biosciences Ltd Q4 and FY22 Results Shows Consolidated Revenue Up by 10%
Hester Biosciences Ltd Reported PAT of Rs. 13.29 Crore in Q3FY21, Growth of 72% Y-o-Y